Taken together, these results indicate that AURKA‐mediated acquired CDDP resistance is dependent on eIF4E and its downstream targets in AGS gastric cancer cells and suggest that targeting AURKA can be an effective therapeutic approach in CDDP‐resistant cells. The gene discussed is EIF4E; the disease is gastric cancer.